Tabelle Resistenzen bei Nonfermentern.

Es sind die typischen Resistenten und Empfindlichkeiten einiger Spezies dargestellt. Es liegen nicht ausreichend Daten vor, die eine Erkennung von Resistenzmechanismen durch ein regelbasiertes System zulassen würden.

Species	Resistent	Sensibel	Referenz
Alcaligenes faecalis	Chinolone Co-Trim	Ampicillin/Sulbactam Piperacillin Ceftazidim Ceftriaxon Imipenem Tobramycin	1
Chryseobacterium (Flavobacterium) meningosepticum	Ampicillin, Cephalosporine, Aminoglycoside, Carbapeneme, Aztreonam Tetracyclin Ciprofloxacin Vancomycin	Chinolone Piperacillin amikacin TMP/SMZ Levofloxacin	2, 3
Flavobacterium indologenes	Ampicillin, Cefuroxim Ceftriaxon Aztreonam Amikacin Carbapeneme	Piperacillin, Ceftazidime Ofloxacin Co-Trim	2
Chromobacterium violaceum	Cephalosporine Rifampicin Amikacin Tobramycin	Piperacillin, Imipenem, Ciprofloxacin, Gentamicin, Co-Trim	4, 5
Burkholderia mallei Burkholderia pseudomallei	Chinolone Aminoglycoside	Piperacillin Imipenem Ceftazidim Doxycyclin	6
Burkholderia cepacia	Carbapeneme Piperacillin Ceftazidim Ceftriaxon Aztreonam Aminoglycoside Tigecyclin	Co-Trim	1, 7
Pseudomonas fluorescens	Ampicillin/Sulbactam Ceftriaxon Aztreonam SXT	Ciprofloxacin Piperacillin Ceftazidim Imipenem Tobramycin	1, 7
Pseudomonas stutzeri		sehr sensibel	1, 7
Alcaligenes xylosoxidans ssp. xylosoxydans	Aminoglycoside Ciprofloxacin Ampicillin/Sulbactam Ceftriaxon Aztreonam	Piperacillin Ceftazidim Imipenem Co-Trim	1, 7
Myroides odoratum	Carbapeneme	Minocyclin	2, 8
Aeromonas spp.		Piperacillin Ceftazidim Cefotaxim Imipenem Levofloxacin Co-Trim	7

1. Fass RJ, Barnishan J, Solomon MC, Ayers LW. In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli. Antimicrob Agents Chemother 1996; 40: 1412-8.

2. Fraser SL, Jorgensen JH. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother 1997; 41: 2738-41.

3. Rossolini GM, Franceschini N, Riccio ML, Mercuri PS, Perilli M, Galleni M, Frere JM, Amicosante G. Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B beta-lactamase showing a broad substrate profile. Biochem J 1998; 332 ( Pt 1): 145-52.

4. Aldridge KE, Valainis GT, Sanders CV. Comparison of the in vitro activity of ciprofloxacin and 24 other antimicrobial agents against clinical strains of Chromobacterium violaceum. Diagn Microbiol Infect Dis 1988; 10: 31-9.

5.Fantinatti-Garboggini F, Almeida R, Portillo Vdo A, Barbosa TA, Trevilato PB, Neto CE, Coelho RD, Silva DW, Bartoleti LA, Hanna ES, Brocchi M, Manfio GP. Drug resistance in Chromobacterium violaceum. Genet Mol Res 2004; 3: 134-47.

6. Thibault FM, Hernandez E, Vidal DR, Girardet M, Cavallo JD,. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. J Antimicrob Chemother 2004; 54: 1134-8.

7. Sader HS, Jones RN. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents 2005; 25: 95-109.

8. Mammeri H, Bellais S, Nordmann P. Chromosome-encoded beta-lactamases TUS-1 and MUS-1 from Myroides odoratus and Myroides odoratimimus (formerly Flavobacterium odoratum), new members of the lineage of molecular subclass B1 metalloenzymes. Antimicrob Agents Chemother 2002; 46: 3561-7.